BRD4 and gastric cancer: Further multivariate Cox analyses showed that, except for chemotherapy conditions, the other three features were independent risk factors for GC patients, in which high BRD4 indicated poor prognosis with an HR of 2.228 (95% CI 1.642–3.023; p < 0.001) for DFS and an HR of 2.232 (95% CI 1.645–3.028; p < 0.001) for DSS (Table 2).